Home Healthcare Equipment in the UK: A Market Snapshot
Home Healthcare Equipment in the UK: A Market Snapshot
Summary
GlobalData's new report - "Home Healthcare Equipment in the UK: A Market Snapshot", explores the UK medical equipment industry. The home healthcare equipment market in the UK was valued at $2.1 billion in 2008. It is forecast to reach $3.8 billion in 2015 with a CAGR of 9%. The need to control healthcare costs, technological advances and increasing number of patients are expected to be the drivers behind this growth. Cost effectiveness of home healthcare has resulted in increased adoption rates of these devices.
While lack of reimbursement for advanced technologies and product recalls remain the key challenges, increasing need to control the rising healthcare costs and positive demographics should ensure that the home healthcare equipment market in the UK continues to grow at a steady pace.
Scope
- Market sizing information to 2015 for the home healthcare market
- Information and comparison of key segments such as Oxygen Concentrators, Positive Airway Pressure Devices, Nebulizers, Infusion Systems, Inhalation Systems, Peritoneal Dialysis Solutions, Hearing Aid Devices, Self Testing IVD Devices, Insulin Delivery Systems and Glucose Monitoring Devices
- Key drivers and challenges to the growth of the UK home healthcare market in the UK
Reasons to buy
- Design market entry and business strategies through insightful analysis of the home healthcare market in the UK
- Understand market dynamics within the UK home healthcare market
- Gain understanding of the key growth opportunities
RELATED REPORTS
US Picture Archiving and Communication Systems (PACS) Market: Increasing Adoption to Drive GrowthSummaryGlobalData’s “US Picture Archiving and Communication Systems (PACS) Market: Increasing Adoption to Drive Growth” report is an essential source of data and analysis on the US PACS market with ...
Industries : Healthcare
BMI calculates that pharmaceutical sales in Venezuela reached VEB7.5bn (US$3.57bn) in 2008. By2013, we forecast the Venezuelan pharmaceutical market will be worth VEB26.0bn, increasing at acompound annual growth rate (CAGR) of 28.23%. BMI notes that as a result of the weakeningVenezuelan bolivar, d ...
Industries : Pharmaceutical, Healthcare
We expect the value of the total pharmaceutical market to increase from US$2.5bn in 2008 to US$4.2bnby 2013, representing a compound annual growth rate (CAGR) of 10.8% in US dollar terms and 8.6% inlocal currency. Per-capita spending on medicines will reach 81.6% by this time while only 0.89% of GDP ...
Industries : Pharmaceutical, Healthcare
BMI calculates that pharmaceutical sales in Portugal reached EUR3.61bn (US$5.31bn) in 2008. Wecalculate that the sales of prescription and over-the-counter (OTC) medicines will reach a value ofEUR0.302bn by 2013, equating to a constant annual growth rate (CAGR) of 2.79% in local currencyterms. We no ...
Industries : Pharmaceutical, Healthcare
BMI calculates that Lithuania’s pharmaceutical market reached a value of LTL1.70bn (US$0.70bn) in2008. By 2013, we expect the value of the prescription and over-the-counter (OTC) markets to reach avalue of LTL2.13bn, equating to a compound annual growth rate (CAGR) of 4.61% over the forecastperiod ...
Industries : Pharmaceutical, Healthcare
The global outlook series on Hospitals provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings. The report offers insight into the industry’s performance in the wake of an expanding global population, rising incidence of chronic illnesses and incre ...
Industries : Medical Facility, Healthcare
INDUSTRY RISK RATINGS REPORTThis is the replacement for August 2009 edition of Health Stores in the US Industry Risk Ratings Report.Industry Risk Ratings SynopsisThis Industry Risk Ratings report evaluates the inherent risks associated with the Health Stores in the US industry. Industry Risk is as ...
Industries : Pharmacies and Personal Care Stores, Healthcare
A brief recession and the devaluation of the local currency have demonstrated that Belarus has not beenable to escape the global economic crisis, although sheer lack of integration into the global financialsystem has done much to blunt its impact. According to BMI, the country’s pharmaceutical sec ...
Industries : Pharmaceutical, Healthcare
We expect total drug spending in Lebanon to increase from under US$500mn in 2008 to US$605mn in2013, a compound annual growth rate (CAGR) of 3.9% in US dollar terms, with 1.75% of GDP dedicatedto pharmaceutical expenditure by 2013.The Minister of Health, Mohammad Jawad Khalifeh, has held the positio ...
Industries : Pharmaceutical, Healthcare
IntroductionParallel trade is a legitimate method of pharmaceutical import and export within the EU zone. Although previously recognized in North America as illegal, cross-border reimportation is now permitted following legislation allowing drugs to be imported into the US from Canada. However, coun ...
Industries : Healthcare, Pharmaceutical
Related industries
reportlinker.com © Copyright 2009. All rights reserved